Danaher Co. (NYSE:DHR) Shares Bought by True North Advisors LLC

True North Advisors LLC lifted its stake in shares of Danaher Co. (NYSE:DHR) by 70.8% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 1,720 shares of the conglomerate’s stock after buying an additional 713 shares during the quarter. True North Advisors LLC’s holdings in Danaher were worth $395,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently bought and sold shares of DHR. Fort Pitt Capital Group LLC lifted its position in shares of Danaher by 3.2% during the third quarter. Fort Pitt Capital Group LLC now owns 238,092 shares of the conglomerate’s stock worth $66,194,000 after purchasing an additional 7,421 shares in the last quarter. Good Life Advisors LLC purchased a new position in Danaher in the 3rd quarter valued at about $217,000. ORG Partners LLC grew its stake in shares of Danaher by 1,212.8% during the fourth quarter. ORG Partners LLC now owns 2,770 shares of the conglomerate’s stock valued at $636,000 after acquiring an additional 2,559 shares in the last quarter. Harvest Portfolios Group Inc. lifted its stake in shares of Danaher by 1.2% in the third quarter. Harvest Portfolios Group Inc. now owns 202,263 shares of the conglomerate’s stock worth $56,233,000 after acquiring an additional 2,465 shares in the last quarter. Finally, Stifel Financial Corp boosted its holdings in Danaher by 1.3% in the third quarter. Stifel Financial Corp now owns 847,348 shares of the conglomerate’s stock valued at $235,583,000 after purchasing an additional 11,216 shares during the last quarter. 79.05% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

DHR has been the topic of several analyst reports. Wolfe Research upgraded Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price objective on the stock in a report on Thursday, October 31st. Robert W. Baird dropped their price target on shares of Danaher from $278.00 to $277.00 and set an “outperform” rating for the company in a research note on Wednesday, October 23rd. Raymond James reduced their price objective on shares of Danaher from $300.00 to $275.00 and set an “outperform” rating on the stock in a research note on Tuesday. StockNews.com lowered shares of Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, December 14th. Finally, Guggenheim initiated coverage on Danaher in a research note on Thursday, December 19th. They issued a “buy” rating and a $275.00 price target for the company. Six equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $285.55.

Danaher Trading Up 0.0 %

Shares of NYSE:DHR opened at $244.19 on Thursday. The company has a 50 day moving average of $234.84 and a 200-day moving average of $253.53. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. The firm has a market cap of $176.38 billion, a P/E ratio of 46.60, a P/E/G ratio of 4.43 and a beta of 0.83. Danaher Co. has a twelve month low of $225.42 and a twelve month high of $281.70.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, topping analysts’ consensus estimates of $1.57 by $0.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The company had revenue of $5.80 billion for the quarter, compared to the consensus estimate of $5.59 billion. During the same quarter in the previous year, the business earned $2.02 EPS. The company’s quarterly revenue was up 3.1% compared to the same quarter last year. As a group, analysts anticipate that Danaher Co. will post 7.5 earnings per share for the current fiscal year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Friday, December 27th will be issued a $0.27 dividend. The ex-dividend date is Friday, December 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.44%. Danaher’s payout ratio is currently 20.61%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.